Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 6 studies | 32% ± 13% | |
endothelial cell | 5 studies | 22% ± 2% | |
basal cell | 4 studies | 25% ± 6% | |
macrophage | 4 studies | 17% ± 2% | |
classical monocyte | 3 studies | 27% ± 4% | |
myeloid cell | 3 studies | 22% ± 2% | |
squamous epithelial cell | 3 studies | 39% ± 19% | |
ciliated cell | 3 studies | 20% ± 5% | |
GABAergic neuron | 3 studies | 19% ± 5% | |
glutamatergic neuron | 3 studies | 22% ± 4% | |
transit amplifying cell | 3 studies | 24% ± 8% | |
adipocyte | 3 studies | 19% ± 2% | |
astrocyte | 3 studies | 21% ± 3% | |
interneuron | 3 studies | 20% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 7898.18 | 459 / 459 | 100% | 73.15 | 1118 / 1118 |
esophagus | 100% | 7965.94 | 1445 / 1445 | 100% | 78.68 | 183 / 183 |
lung | 100% | 6803.62 | 578 / 578 | 100% | 53.02 | 1155 / 1155 |
ovary | 100% | 7083.69 | 180 / 180 | 100% | 52.62 | 430 / 430 |
prostate | 100% | 6280.92 | 245 / 245 | 100% | 46.92 | 502 / 502 |
uterus | 100% | 9005.84 | 170 / 170 | 100% | 57.40 | 459 / 459 |
thymus | 100% | 6231.50 | 653 / 653 | 100% | 45.16 | 604 / 605 |
intestine | 100% | 7408.78 | 966 / 966 | 100% | 51.98 | 526 / 527 |
bladder | 100% | 7445.62 | 21 / 21 | 100% | 49.80 | 503 / 504 |
stomach | 100% | 5087.32 | 359 / 359 | 100% | 60.59 | 285 / 286 |
skin | 100% | 8938.85 | 1809 / 1809 | 99% | 49.48 | 469 / 472 |
kidney | 100% | 6195.09 | 89 / 89 | 99% | 61.52 | 895 / 901 |
pancreas | 99% | 3567.64 | 326 / 328 | 99% | 52.86 | 176 / 178 |
adrenal gland | 100% | 5938.96 | 258 / 258 | 97% | 23.77 | 222 / 230 |
liver | 100% | 2840.04 | 226 / 226 | 93% | 24.22 | 379 / 406 |
brain | 92% | 2488.67 | 2418 / 2642 | 99% | 30.46 | 699 / 705 |
adipose | 100% | 7595.39 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 6358.68 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 35.65 | 29 / 29 |
muscle | 100% | 4903.98 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 7044.28 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 68.68 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 34.09 | 1 / 1 |
peripheral blood | 99% | 9423.27 | 919 / 929 | 0% | 0 | 0 / 0 |
heart | 98% | 2873.25 | 844 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 33.11 | 78 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0032869 | Biological process | cellular response to insulin stimulus |
GO_0043536 | Biological process | positive regulation of blood vessel endothelial cell migration |
GO_0045766 | Biological process | positive regulation of angiogenesis |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0071391 | Biological process | cellular response to estrogen stimulus |
GO_0033194 | Biological process | response to hydroperoxide |
GO_1905564 | Biological process | positive regulation of vascular endothelial cell proliferation |
GO_1904568 | Biological process | cellular response to wortmannin |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_1902004 | Biological process | positive regulation of amyloid-beta formation |
GO_0043923 | Biological process | positive regulation by host of viral transcription |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_1904828 | Biological process | positive regulation of hydrogen sulfide biosynthetic process |
GO_0048511 | Biological process | rhythmic process |
GO_0034224 | Biological process | cellular response to zinc ion starvation |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0032993 | Cellular component | protein-DNA complex |
GO_0000791 | Cellular component | euchromatin |
GO_0005654 | Cellular component | nucleoplasm |
GO_0017053 | Cellular component | transcription repressor complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0043425 | Molecular function | bHLH transcription factor binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0060090 | Molecular function | molecular adaptor activity |
GO_0043565 | Molecular function | sequence-specific DNA binding |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_0003690 | Molecular function | double-stranded DNA binding |
GO_0001221 | Molecular function | transcription coregulator binding |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0035035 | Molecular function | histone acetyltransferase binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0042826 | Molecular function | histone deacetylase binding |
Gene name | SP1 |
Protein name | Sp1 transcription factor, isoform CRA_a (cDNA, FLJ92269) Transcription factor Sp1 Pregnancy-specific protein Sp1 transcription factor Alternative protein SP1 |
Synonyms | TSFP1 hCG_1787889 |
Description | FUNCTION: Transcription factor that can activate or repress transcription in response to physiological and pathological stimuli. Binds with high affinity to GC-rich motifs and regulates the expression of a large number of genes involved in a variety of processes such as cell growth, apoptosis, differentiation and immune responses. Highly regulated by post-translational modifications (phosphorylations, sumoylation, proteolytic cleavage, glycosylation and acetylation). Binds also the PDGFR-alpha G-box promoter. May have a role in modulating the cellular response to DNA damage. Implicated in chromatin remodeling. Plays an essential role in the regulation of FE65 gene expression. In complex with ATF7IP, maintains telomerase activity in cancer cells by inducing TERT and TERC gene expression. Isoform 3 is a stronger activator of transcription than isoform 1. Positively regulates the transcription of the core clock component BMAL1 . Plays a role in the recruitment of SMARCA4/BRG1 on the c-FOS promoter. Plays a role in protecting cells against oxidative stress following brain injury by regulating the expression of RNF112 (By similarity). . |
Accessions | L8E7F4 ENST00000426431.2 [P08047-2] B2R4Y6 ENST00000548560.1 ENST00000551969.5 P08047 H3BUU5 Q15403 H3BVI2 ENST00000327443.9 [P08047-1] |